Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-06-036217
Filing Date
2006-06-13
Accepted
2006-06-13 15:05:32
Documents
1
Period of Report
2006-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4752
  Complete submission text file 0001209191-06-036217.txt   6584
Mailing Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101
Business Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101 2066237612
TARGETED GENETICS CORP /WA/ (Issuer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1100 OLIVE WAY SUITE 100 SEATTLE WA 98101
Business Address 206-521-7881
Poston David J (Reporting) CIK: 0001337173 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23930 | Film No.: 06902194